HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).

AbstractBACKGROUND:
Early appearance of antibodies specific for native human type II collagen (anti-CII) characterizes an early inflammatory and destructive phenotype in adults with rheumatoid arthritis (RA). The objective of this study was to investigate the occurrence of anti-CII, IgM RF, IgA RF and anti-CCP in serum samples obtained early after diagnosis, and to relate the occurrence of autoantibodies to outcome after eight years of disease in children with juvenile idiopathic arthritis (JIA).
METHODS:
The Nordic JIA database prospectively included JIA patients followed for eight years with data on remission and joint damage. From this database, serum samples collected from 192 patients, at a median of four months after disease onset, were analysed for IgG anti-CII, IgM RF, IgA RF and IgG anti-CCP. Joint damage was assessed based on Juvenile Arthritis Damage Index for Articular damage (JADI-A), a validated clinical instrument for joint damage.
RESULTS:
Elevated serum levels of anti-CII occurred in 3.1%, IgM RF in 3.6%, IgA RF in 3.1% and anti-CCP in 2.6% of the patients. Occurrence of RF and anti-CCP did to some extent overlap, but rarely with anti-CII. The polyarticular and oligoarticular extended categories were overrepresented in patients with two or more autoantibodies. Anti-CII occurred in younger children, usually without overlap with the other autoantibodies and was associated with high levels of C-reactive protein (CRP) early in the disease course. All four autoantibodies were significantly associated with joint damage, but not with active disease at the eight-year follow up.
CONCLUSIONS:
Anti-CII, anti-CCP, IgA RF and IgM RF detected early in the disease course predicted joint damage when assessed after eight years of disease. The role of anti-CII in JIA should be further studied.
AuthorsLillemor Berntson, Ellen Nordal, Anders Fasth, Kristiina Aalto, Troels Herlin, Susan Nielsen, Marite Rygg, Marek Zak, Johan Rönnelid, Nordic Study Group of Pediatric Rheumatology (NoSPeR)
JournalPediatric rheumatology online journal (Pediatr Rheumatol Online J) Vol. 12 Pg. 22 ( 2014) ISSN: 1546-0096 [Print] England
PMID24944545 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Biomarkers
  • Collagen Type II
  • Immunoglobulin A
  • Immunoglobulin M
  • Rheumatoid Factor
Topics
  • Adult
  • Age of Onset
  • Arthritis, Juvenile (diagnosis, epidemiology, immunology)
  • Arthritis, Rheumatoid (diagnosis, epidemiology, immunology)
  • Autoantibodies (blood)
  • Biomarkers (blood)
  • Child
  • Collagen Type II (immunology)
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin A (blood)
  • Immunoglobulin M (blood)
  • Male
  • Prognosis
  • Rheumatoid Factor (blood)
  • Scandinavian and Nordic Countries (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: